Big PBM Markups

What the FTC Reports Reveal—And Where ClearScript Stands

Play this video

The FTC’s interim reports on PBMs highlight a troubling trend: sky-high markups on specialty generics. In this webinar, ClearScript’s President Brad Skatter reviews the findings and shares our own analysis built on transparency, fiduciary responsibility, and data-backed results. ClearScript is different – watch to learn how.